A Rare Presentation of Cryptococcal Meningitis in a Treatment-Naive Patient with Sarcoidosis

Mehak Qureshi1, Basel Abdelazeem1, Ashiya Khan1

  • 1McLaren Health Care, Flint/Michigan State University, Flint, Michigan, USA.

Insights

Opportunistic fungal infections like cryptococcosis can occur in sarcoidosis patients, even if they have not started treatment. This case highlights the need to consider fungal infections in asymptomatic, treatment-naive sarcoidosis patients.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Immunology

Background:

  • Cryptococcus neoformans is an encapsulated fungus found in the environment.
  • Cryptococcosis is an opportunistic infection common in immunocompromised individuals (HIV, transplant recipients, malignancy, steroid users).
  • Rare cases of cryptococcosis have been reported in sarcoidosis patients, particularly those on steroids.

Purpose of the Study:

  • To emphasize the importance of considering opportunistic fungal infections in asymptomatic, treatment-naive sarcoidosis patients.
  • To present a case of cryptococcal meningitis in a patient with untreated, asymptomatic sarcoidosis and idiopathic T-cell lymphopenia.

Main Methods:

  • Case report presentation.
  • Clinical diagnosis of cryptococcal meningitis.
  • Assessment of patient's sarcoidosis status (asymptomatic, treatment-naive).
  • Identification of underlying T-cell lymphopenia.

Main Results:

  • A patient with asymptomatic, treatment-naive sarcoidosis developed cryptococcal meningitis.
  • The patient presented with headache and was found to have idiopathic T-cell lymphopenia.
  • This case underscores the potential for cryptococcosis in sarcoidosis patients without typical risk factors.

Conclusions:

  • Cryptococcosis is an opportunistic infection primarily seen in immunocompromised individuals.
  • Sarcoidosis is a granulomatous disease affecting multiple organs, commonly the lungs.
  • Opportunistic fungal infections should be considered in asymptomatic, treatment-naive sarcoidosis patients, even in the absence of steroid use.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
183
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
419
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
236
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
527
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
674
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
269